Modi-1 in Breast, Head and Neck, Ovarian, or Renal Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Renal Cell Cancer|High Grade Ovarian Serous Adenocarcinoma|Squamous Cell Carcinoma of the Head and Neck
Interventions: BIOLOGICAL: Modi-1/Modi-1v|BIOLOGICAL: Pembrolizumab|DEVICE: MicronJet600™ microneedle device (NanoPass)
Sponsor: Scancell Ltd